Question 1

What is the catalog number for Evofosfamide (TH-302)?

Accepted Answer

The catalog number for Evofosfamide (TH-302) is C17048.

Question 2

What sizes are available for Evofosfamide (TH-302)?

Accepted Answer

Evofosfamide (TH-302) is available in the following size(s): 5 mg.

Question 3

Is Evofosfamide (TH-302) in stock?

Accepted Answer

Evofosfamide (TH-302) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Are there any special shipping requirements for Evofosfamide (TH-302)?

Accepted Answer

Evofosfamide (TH-302) is requires dry ice shipping.

Question 5

What should I check when this product first arrives?

Accepted Answer

Inspect the package immediately for transportation damage, ice loss, leakage, or breakage. Report any issues right away with photos and your order reference; our specialists will determine whether the product is still usable or needs replacing.

Question 6

Does this cell line or biologic require a Material Transfer Agreement (MTA)?

Accepted Answer

Some products, including certain cell lines, plasmids, and tissue cultures, are subject to intellectual property terms and may require an MTA before we can ship. We’ll inform you in advance if this product requires one, and additional handling fees may apply.

Question 7

What should I do if I need to report a performance issue with a specific lot of this product?

Accepted Answer

Provide the catalogue number, product name, lot number, and your experimental results to our technical support team. They’ll investigate and, if needed, escalate to the manufacturer, provided the product was used before expiry and stored correctly.

Evofosfamide (TH-302)

Product Specifications

CAS Number

SKU

Target

Applications

Smiles

Molecular Formula

Additionnal Information

Storage Conditions

Frequently Asked Questions

Explore Other Products

Trichohyalin HDR Plasmid (m)

PDS5B Antibody

Anti-SET Monoclonal Antibody

SPATA31D4 Human Over-expression Lysate

Human SULT2B1 Protein (Met 1-Ser 365) [His]

LMO7 sgRNA CRISPR Lentivector (Human) (Target 2)